Home › Leerink Swann Issues Q4 2016 Earnings Estimate for Regeneron Pharmaceuticals
 

Keywords :   


Leerink Swann Issues Q4 2016 Earnings Estimate for Regeneron Pharmaceuticals

2015-11-08 00:21:39| Biotech - Topix.net

Leerink Swann issued their Q4 2016 earnings per share estimates for Regeneron Pharmaceuticals in a report issued on Thursday, Zacks reports. Leerink Swann analyst J. Schwartz expects that the brokerage will post earnings of $2.79 per share for the quarter.

Tags: issues estimate earnings pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
More »